No profile data available.
HeartBeam, Inc. (BEAT) is a healthcare company in the heart treatment equipment industry, based in Santa Clara, United States, with about 16 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$21.02 million. In Q1 2026 (the quarter ended March 31, 2026) revenue was $0. Its largest business segment, MonitoringCommercial, brought in 50% of segment revenue in fiscal year 2019. Its market capitalization was $27.06 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility.
HeartBeam reported $0 in revenue for fiscal year 2025. In Q1 2026 revenue was $0.
MonitoringCommercial, with $218.27 million or 50% of segment revenue in fiscal year 2019. Next: MonitoringMedicare (35%) and ClinicalTrialSupportandRelatedServices (12%).
$27.06 million as of October 9, 2026.
Listed companies of a similar size in the same industry (heart treatment equipment) include Stereotaxis, Inc. (STXS), Streamex Corp. (STEX), CVRx, Inc. (CVRX), Picard Medical, Inc. (PMI).